1.
Fei Tian, Dong Liu, Na Wei, et al. Prediction of tumor origin in cancers of unknown primary origin with cytology-based deep learning. Nature Medicine. 2024:1-11. doi:10.1038/s41591-024-02915-w
Cancer
1.
Haonan Song, Haoyuan Jiang, Weichu Hu, et al. Cervical extracellular matrix hydrogel optimizes tumor heterogeneity of cervical squamous cell carcinoma organoids. Science Advances. 2024;10(20):eadl3511. doi:10.1126/sciadv.adl3511
1.
Tengku Ibrahim Maulana, Claudia Teufel, Madalena Cipriano, et al. Breast cancer-on-chip for patient-specific efficacy and safety testing of CAR-T cells. Cell Stem Cell. 2024;31(7):989-1002.e9. doi:10.1016/j.stem.2024.04.018
1.
Marius F. Harter, Timothy Recaldin, Regine Gerard, et al. Analysis of off-tumour toxicities of T-cell-engaging bispecific antibodies via donor-matched intestinal organoids and tumouroids. Nature Biomedical Engineering. 2024;8:345-360. doi:10.1038/s41551-023-01156-5
1.
Hojjatollah Nazari, Ann-Na Cho, Dale Goss, Jean Paul Thiery, Majid Ebrahimi Warkiani. Impact of brain organoid-derived sEVs on metastatic adaptation and invasion of breast carcinoma cells through a microphysiological system. Lab on a Chip. 2024;24(14):3434-3455. doi:10.1039/D4LC00296B
1.
Miwako Sase, Taku Sato, Hajime Sato, et al. Comparative analysis of tongue cancer organoids among patients identifies the heritable nature of minimal residual disease. Developmental Cell. 2024. doi:10.1016/j.devcel.2024.10.007
1.
Alice Scemama, Sophia Lunetto, Artysha Tailor, et al. Hybrid Cancer Stem Cells Utilise Vascular Tracks for Collective Streaming Invasion in a Metastasis-on-a-Chip Device.; 2024. doi:10.1101/2024.01.02.573897
1.
B. Yetkin-Arik, S. A. Jansen, S. Varderidou-Minasian, et al. Mesenchymal stromal/stem cells promote intestinal epithelium regeneration after chemotherapy-induced damage. Stem Cell Research & Therapy. 2024;15(1):125. doi:10.1186/s13287-024-03738-9
1.
Anastasia Brooks, Yali Zhang, Jiezhong Chen, Chun-Xia Zhao. Cancer Metastasis-on-a-Chip for Modeling Metastatic Cascade and Drug Screening. Advanced Healthcare Materials. 2024;13(21):2302436. doi:10.1002/adhm.202302436
1.
Laura Rüland, Francesco Andreatta, Simone Massalini, et al. Organoid models of fibrolamellar carcinoma mutations reveal hepatocyte transdifferentiation through cooperative BAP1 and PRKAR2A loss. Nature Communications. 2023;14(1):2377. doi:10.1038/s41467-023-37951-6